Detalhe da pesquisa
1.
Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy.
Hepatology
; 78(2): 592-606, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36896974
2.
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease.
Lipids Health Dis
; 23(1): 31, 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287401
3.
HIGD2A silencing impairs hepatocellular carcinoma growth via inhibiting mitochondrial function and the MAPK/ERK pathway.
J Transl Med
; 21(1): 253, 2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041638
4.
Mitochondrial HIGD1A inhibits hepatitis B virus transcription and replication through the cellular PNKD-NF-κB-NR2F1 nexus.
J Med Virol
; 95(4): e28749, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185850
5.
Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc-ODC1 nexus.
Cancer Metab
; 12(1): 7, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395945
6.
Targeting cIAPs attenuates CCl4-induced liver fibrosis by increasing MMP9 expression derived from neutrophils.
Life Sci
; 289: 120235, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914932
7.
Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma.
Front Oncol
; 11: 700700, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490100
8.
Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
J Comput Biol
; 26(5): 485-494, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30864827